Advancements in dry eye managment

home / viewpoints / advancements-in-dry-eye-managment

Marguerite McDonald, MD, Eric Donnenfeld, MD, Tracy Swartz, OD, MS, FAAO, and Crystal Brimer, OD, FAAO, discuss a number of topics pertaining to dry eye, including the diagnosis and clinical manifestations, traditional, treatment options, and the potential new agents in the horizon.

Introduction and overview

EP. 1: Introduction and overview

Brooke Henson, Editor;Tracy Schroeder Swartz, OD, MS, FAAO;Marguerite McDonald, MD;Eric Donnenfeld, MD;Crystal Brimer, OD, FAAO
November 18th 2020
Consequences and epidemiology of untreated dry eye

EP. 2: Consequences and epidemiology of untreated dry eye

Brooke Henson, Editor;Tracy Schroeder Swartz, OD, MS, FAAO;Marguerite McDonald, MD;Eric Donnenfeld, MD;Crystal Brimer, OD, FAAO
November 18th 2020
Diagnosis and overlooking asymptomatic patients with DED

EP. 3: Diagnosis and overlooking asymptomatic patients with DED

Brooke Henson, Editor;Tracy Schroeder Swartz, OD, MS, FAAO;Marguerite McDonald, MD;Eric Donnenfeld, MD;Crystal Brimer, OD, FAAO
November 18th 2020
Standard testing and assessment for DED

EP. 4: Standard testing and assessment for DED

Brooke Henson, Editor;Tracy Schroeder Swartz, OD, MS, FAAO;Marguerite McDonald, MD;Eric Donnenfeld, MD;Crystal Brimer, OD, FAAO
November 18th 2020
General Principles of Treatment of DED

EP. 5: General Principles of Treatment of DED

Brooke Henson, Editor;Tracy Schroeder Swartz, OD, MS, FAAO;Marguerite McDonald, MD;Eric Donnenfeld, MD;Crystal Brimer, OD, FAAO
November 18th 2020
OD and MD communication for optimal care

EP. 6: OD and MD communication for optimal care

Brooke Henson, Editor;Tracy Schroeder Swartz, OD, MS, FAAO;Marguerite McDonald, MD;Eric Donnenfeld, MD;Crystal Brimer, OD, FAAO
November 18th 2020
Review of artificial tears for DED

EP. 7: Review of artificial tears for DED

Brooke Henson, Editor;Tracy Schroeder Swartz, OD, MS, FAAO;Marguerite McDonald, MD;Eric Donnenfeld, MD;Crystal Brimer, OD, FAAO
November 18th 2020
Corticosteroids and Immunomodulators for the treatment of dry eye

EP. 8: Corticosteroids and Immunomodulators for the treatment of dry eye

Brooke Henson, Editor;Tracy Schroeder Swartz, OD, MS, FAAO;Marguerite McDonald, MD;Eric Donnenfeld, MD;Crystal Brimer, OD, FAAO
November 18th 2020
Eric Donnenfeld, MD, and Marguerite McDonald, MD, discuss the role of nutritional supplements as well as antibiotics in dry eye management.

EP. 9: The role of nutritional supplements and antibiotics in DED

Brooke Henson, Editor;Tracy Schroeder Swartz, OD, MS, FAAO;Marguerite McDonald, MD;Eric Donnenfeld, MD;Crystal Brimer, OD, FAAO
November 18th 2020
Crystal Brimer, OD, FAAO, identifies the preferred treatment options for meibomian gland dysfunction.

EP. 10: How to treat meibomian gland dysfunction

Brooke Henson, Editor;Tracy Schroeder Swartz, OD, MS, FAAO;Marguerite McDonald, MD;Eric Donnenfeld, MD;Crystal Brimer, OD, FAAO
November 18th 2020
Crystal Brimer, OD, FAAO, shares some in-office procedures for dry eye and the patient resistance with high cost.

EP. 11: In-office procedures and patient resistance for DED treatments

Brooke Henson, Editor;Tracy Schroeder Swartz, OD, MS, FAAO;Marguerite McDonald, MD;Eric Donnenfeld, MD;Crystal Brimer, OD, FAAO
November 18th 2020
Treatments for aqueous dry eye

EP. 12: Treatments for aqueous dry eye

Brooke Henson, Editor;Tracy Schroeder Swartz, OD, MS, FAAO;Marguerite McDonald, MD;Eric Donnenfeld, MD;Crystal Brimer, OD, FAAO
November 18th 2020
Challenges in the management of DED

EP. 13: Challenges in the management of DED

Brooke Henson, Editor;Tracy Schroeder Swartz, OD, MS, FAAO;Marguerite McDonald, MD;Eric Donnenfeld, MD;Crystal Brimer, OD, FAAO
November 18th 2020
Counseling and formulary concerns for DED therapies

EP. 14: Counseling and formulary concerns for DED therapies

Brooke Henson, Editor;Tracy Schroeder Swartz, OD, MS, FAAO;Marguerite McDonald, MD;Eric Donnenfeld, MD;Crystal Brimer, OD, FAAO
November 18th 2020
Overlapping diseases and COVID-19's impact

EP. 15: Overlapping diseases and COVID-19's impact

Brooke Henson, Editor;Tracy Schroeder Swartz, OD, MS, FAAO;Marguerite McDonald, MD;Eric Donnenfeld, MD;Crystal Brimer, OD, FAAO
November 18th 2020
Agents in the pipeline for DED

EP. 16: Agents in the pipeline for DED

Brooke Henson, Editor;Tracy Schroeder Swartz, OD, MS, FAAO;Marguerite McDonald, MD;Eric Donnenfeld, MD;Crystal Brimer, OD, FAAO
November 18th 2020
Novel agents in the pipeline for DED

EP. 17: Novel agents in the pipeline for DED

Brooke Henson, Editor;Tracy Schroeder Swartz, OD, MS, FAAO;Marguerite McDonald, MD;Eric Donnenfeld, MD;Crystal Brimer, OD, FAAO
November 18th 2020
© 2023 MJH Life Sciences

All rights reserved.